A Perspective on the Quality of Life of Hemophilia A Patients in Romania—A Study on 100 Patients
Journal of Vascular Diseases · 2022
DOI: 10.3390/jvd1020012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Diseases, 2022. Verfasst von Catalina Guran und 5 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hemophilia A is an X-linked coagulopathy, where there is a deficit in the production of the coagulation factor VIII. Even though there is a higher incidence of hemophilia A than of hemophilia B, it is still considered a rare disease, as its incidence is of 1 in 10,000 people born. We have applied three questionnaires regarding quality of life: Haem-A-QoL, Haemo-SYM and EQ-5D-5L to 101 adult patients with hemophilia A, which were separated into two groups: on-demand and prophylactic treatment. The results showed a relatively young lot, with medium and high education, but with a sedentary lifestyle and are pensioners. They also seem to have moderate mobility issues but, overall, a good quality of life. The quality of life in our studied lot is relatively good, but a more diverse lot is advised.
Zitieren
APA
Guran, C., Ioniţă, H. M., Haţegan, M., Ioniţă, I., Trăilă, A., & Ilie, A. (2022). A Perspective on the Quality of Life of Hemophilia A Patients in Romania—A Study on 100 Patients. Journal of Vascular Diseases. https://doi.org/10.3390/jvd1020012
Vancouver
Guran C, Ioniţă HM, Haţegan M, Ioniţă I, Trăilă A, Ilie A. A Perspective on the Quality of Life of Hemophilia A Patients in Romania—A Study on 100 Patients. Journal of Vascular Diseases. 2022. doi:10.3390/jvd1020012
BibTeX
@article{Guran2022,
author = {Guran, Catalina and Ioniţă, Hortensia Mărioara and Haţegan, Mieta-Gabriela and Ioniţă, Ioana and Trăilă, Adina and Ilie, Alina-Maria},
title = {A Perspective on the Quality of Life of Hemophilia A Patients in Romania—A Study on 100 Patients},
journal = {Journal of Vascular Diseases},
year = {2022},
doi = {10.3390/jvd1020012}
}
EUVIMED